TWI438264B - Plastic film and infusion bag having oxigen absorption capability - Google Patents
Plastic film and infusion bag having oxigen absorption capability Download PDFInfo
- Publication number
- TWI438264B TWI438264B TW99137466A TW99137466A TWI438264B TW I438264 B TWI438264 B TW I438264B TW 99137466 A TW99137466 A TW 99137466A TW 99137466 A TW99137466 A TW 99137466A TW I438264 B TWI438264 B TW I438264B
- Authority
- TW
- Taiwan
- Prior art keywords
- layer
- plastic film
- unsaturated
- copolymer
- adjacent
- Prior art date
Links
- 239000002985 plastic film Substances 0.000 title claims description 42
- 229920006255 plastic film Polymers 0.000 title claims description 42
- 238000001802 infusion Methods 0.000 title claims description 20
- 238000010521 absorption reaction Methods 0.000 title description 7
- 238000007789 sealing Methods 0.000 claims description 73
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 61
- 229910052760 oxygen Inorganic materials 0.000 claims description 61
- 239000001301 oxygen Substances 0.000 claims description 61
- -1 transition metal salt Chemical class 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 29
- 229920001577 copolymer Polymers 0.000 claims description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 25
- 229910052799 carbon Inorganic materials 0.000 claims description 25
- 238000002844 melting Methods 0.000 claims description 25
- 230000008018 melting Effects 0.000 claims description 25
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims description 23
- 239000004711 α-olefin Substances 0.000 claims description 23
- 229920000642 polymer Polymers 0.000 claims description 22
- 239000000178 monomer Substances 0.000 claims description 20
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 18
- 238000012643 polycondensation polymerization Methods 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 150000004291 polyenes Chemical class 0.000 claims description 16
- 239000004698 Polyethylene Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 229920000573 polyethylene Polymers 0.000 claims description 14
- 238000001125 extrusion Methods 0.000 claims description 12
- 229920001903 high density polyethylene Polymers 0.000 claims description 12
- 239000004700 high-density polyethylene Substances 0.000 claims description 12
- 229910052723 transition metal Inorganic materials 0.000 claims description 12
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 11
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 claims description 10
- 150000004985 diamines Chemical class 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 229920000092 linear low density polyethylene Polymers 0.000 claims description 9
- 239000004707 linear low-density polyethylene Substances 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims 5
- 101000939676 Androctonus crassicauda Toxin a Proteins 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 239000010410 layer Substances 0.000 description 241
- 230000000052 comparative effect Effects 0.000 description 18
- 229920000098 polyolefin Polymers 0.000 description 17
- 239000011229 interlayer Substances 0.000 description 16
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 14
- 239000000126 substance Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 229920000768 polyamine Polymers 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 150000001451 organic peroxides Chemical class 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000004888 barrier function Effects 0.000 description 9
- 238000000889 atomisation Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000005054 agglomeration Methods 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 7
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 6
- 239000005977 Ethylene Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000010525 oxidative degradation reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 5
- 229920000571 Nylon 11 Polymers 0.000 description 5
- 239000012790 adhesive layer Substances 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000001771 impaired effect Effects 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 4
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 4
- 239000005062 Polybutadiene Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 150000001993 dienes Chemical class 0.000 description 4
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920002857 polybutadiene Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920001195 polyisoprene Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- DCTOHCCUXLBQMS-UHFFFAOYSA-N 1-undecene Chemical compound CCCCCCCCCC=C DCTOHCCUXLBQMS-UHFFFAOYSA-N 0.000 description 2
- PBLZLIFKVPJDCO-UHFFFAOYSA-N 12-aminododecanoic acid Chemical compound NCCCCCCCCCCCC(O)=O PBLZLIFKVPJDCO-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 239000003484 crystal nucleating agent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000004512 die casting Methods 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- MLQPXAQSJNFRRZ-UHFFFAOYSA-N n-decyldodecan-1-amine Chemical compound CCCCCCCCCCCCNCCCCCCCCCC MLQPXAQSJNFRRZ-UHFFFAOYSA-N 0.000 description 2
- 239000002667 nucleating agent Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- ALBAONCGXKQWRY-UHFFFAOYSA-N (2-butylphenoxy)methanol Chemical compound CCCCC1=CC=CC=C1OCO ALBAONCGXKQWRY-UHFFFAOYSA-N 0.000 description 1
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical compound O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 1
- MRERMGPPCLQIPD-NBVRZTHBSA-N (3beta,5alpha,9alpha,22E,24R)-3,5,9-Trihydroxy-23-methylergosta-7,22-dien-6-one Chemical compound C1C(O)CCC2(C)C(CCC3(C(C(C)/C=C(\C)C(C)C(C)C)CCC33)C)(O)C3=CC(=O)C21O MRERMGPPCLQIPD-NBVRZTHBSA-N 0.000 description 1
- QFGCFKJIPBRJGM-UHFFFAOYSA-N 12-[(2-methylpropan-2-yl)oxy]-12-oxododecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCC(O)=O QFGCFKJIPBRJGM-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-N 7,7-dimethyloctanoic acid Chemical compound CC(C)(C)CCCCCC(O)=O YPIFGDQKSSMYHQ-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LTHGVQSIQKOILI-UHFFFAOYSA-N C(CCCCCCCCC)N.CCCCCCCCCCC Chemical compound C(CCCCCCCCC)N.CCCCCCCCCCC LTHGVQSIQKOILI-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- JGMGACOBRZDNAZ-UHFFFAOYSA-N N1C(=CC2=CC=CC=C12)N.CCCCCCCCCCC Chemical compound N1C(=CC2=CC=CC=C12)N.CCCCCCCCCCC JGMGACOBRZDNAZ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 229920003355 Novatec® Polymers 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 229920000572 Nylon 6/12 Polymers 0.000 description 1
- 239000004959 Rilsan Substances 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- NIDNOXCRFUCAKQ-UHFFFAOYSA-N bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2C(O)=O NIDNOXCRFUCAKQ-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- UPIWXMRIPODGLE-UHFFFAOYSA-N butyl benzenecarboperoxoate Chemical group CCCCOOC(=O)C1=CC=CC=C1 UPIWXMRIPODGLE-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 150000001845 chromium compounds Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- KDMCQAXHWIEEDE-UHFFFAOYSA-L cobalt(2+);7,7-dimethyloctanoate Chemical compound [Co+2].CC(C)(C)CCCCCC([O-])=O.CC(C)(C)CCCCCC([O-])=O KDMCQAXHWIEEDE-UHFFFAOYSA-L 0.000 description 1
- AMFIJXSMYBKJQV-UHFFFAOYSA-L cobalt(2+);octadecanoate Chemical compound [Co+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O AMFIJXSMYBKJQV-UHFFFAOYSA-L 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000012792 core layer Substances 0.000 description 1
- 229920005565 cyclic polymer Polymers 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 150000002736 metal compounds Chemical group 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002587 poly(1,3-butadiene) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/07—Flat, e.g. panels
- B29C48/08—Flat, e.g. panels flexible, e.g. films
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
- B29C48/10—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels flexible, e.g. blown foils
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/16—Articles comprising two or more components, e.g. co-extruded layers
- B29C48/18—Articles comprising two or more components, e.g. co-extruded layers the components being layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
- B32B27/08—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/30—Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
- B32B27/306—Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers comprising vinyl acetate or vinyl alcohol (co)polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/34—Layered products comprising a layer of synthetic resin comprising polyamides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
- B65D65/38—Packaging materials of special type or form
- B65D65/40—Applications of laminates for particular packaging purposes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/16—Articles comprising two or more components, e.g. co-extruded layers
- B29C48/18—Articles comprising two or more components, e.g. co-extruded layers the components being layers
- B29C48/21—Articles comprising two or more components, e.g. co-extruded layers the components being layers the layers being joined at their surfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/25—Component parts, details or accessories; Auxiliary operations
- B29C48/30—Extrusion nozzles or dies
- B29C48/305—Extrusion nozzles or dies having a wide opening, e.g. for forming sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/06—PE, i.e. polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/06—PE, i.e. polyethylene
- B29K2023/0608—PE, i.e. polyethylene characterised by its density
- B29K2023/0625—LLDPE, i.e. linear low density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/06—PE, i.e. polyethylene
- B29K2023/0608—PE, i.e. polyethylene characterised by its density
- B29K2023/065—HDPE, i.e. high density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/08—Copolymers of ethylene
- B29K2023/086—EVOH, i.e. ethylene vinyl alcohol copolymer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2077/00—Use of PA, i.e. polyamides, e.g. polyesteramides or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2223/00—Use of polyalkenes or derivatives thereof as reinforcement
- B29K2223/04—Polymers of ethylene
- B29K2223/06—PE, i.e. polyethylene
- B29K2223/0608—PE, i.e. polyethylene characterised by its density
- B29K2223/065—HDPE, i.e. high density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2423/00—Use of polyalkenes or derivatives thereof as filler
- B29K2423/04—Polymers of ethylene
- B29K2423/06—PE, i.e. polyethylene
- B29K2423/0608—PE, i.e. polyethylene characterised by its density
- B29K2423/065—HDPE, i.e. high density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2623/00—Use of polyalkenes or derivatives thereof for preformed parts, e.g. for inserts
- B29K2623/04—Polymers of ethylene
- B29K2623/06—PE, i.e. polyethylene
- B29K2623/0608—PE, i.e. polyethylene characterised by its density
- B29K2623/065—HDPE, i.e. high density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2823/00—Use of polyalkenes or derivatives thereof as mould material
- B29K2823/04—Polymers of ethylene
- B29K2823/06—PE, i.e. polyethylene
- B29K2823/0608—PE, i.e. polyethylene characterised by its density
- B29K2823/065—HDPE, i.e. high density polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/712—Containers; Packaging elements or accessories, Packages
- B29L2031/7122—Tea bags
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2250/00—Layers arrangement
- B32B2250/04—4 layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2250/00—Layers arrangement
- B32B2250/05—5 or more layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2250/00—Layers arrangement
- B32B2250/24—All layers being polymeric
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2270/00—Resin or rubber layer containing a blend of at least two different polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/30—Properties of the layers or laminate having particular thermal properties
- B32B2307/31—Heat sealable
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/70—Other properties
- B32B2307/74—Oxygen absorber
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2439/00—Containers; Receptacles
- B32B2439/40—Closed containers
- B32B2439/46—Bags
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2439/00—Containers; Receptacles
- B32B2439/80—Medical packaging
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31725—Of polyamide
- Y10T428/3175—Next to addition polymer from unsaturated monomer[s]
Landscapes
- Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
- Wrappers (AREA)
Description
本發明係有關具有氧吸收功能的醫療用容器用塑膠質薄膜,及使用該塑膠質薄膜之輸液袋。The present invention relates to a plastic film for a medical container having an oxygen absorbing function, and an infusion bag using the plastic film.
本發明係以2009年11月2日於日本申請之專利2009-251627號為基礎並主張優先權,並將其內容援用於本說明書中。The present invention is based on Japanese Patent Application No. 2009-251627, filed on Jan.
輸液、藥液用袋、經腸營養劑等醫療用容器,除了以往的玻璃瓶以外,目前係使用聚乙烯及聚丙烯、聚氯乙烯等經由中空成形或熱黏著製袋後形成的軟袋。其中軟袋由於具備輕量且廢棄時容積小等優點,以及於投藥時無須使用可能造成院內感染之通氣針,而成為醫療用容器的主流。In addition to conventional glass bottles, medical containers such as infusions, liquid medicine bags, and enteral nutrients are currently made of polyethylene, polypropylene, polyvinyl chloride, or the like, which are formed by hollow molding or heat-bonding. Among them, the soft bag has the advantages of being lightweight and having a small volume at the time of disposal, and is not required to use a ventilating needle which may cause nosocomial infection during administration, and has become a mainstream of medical containers.
以往使用於軟袋的薄膜,由於為了降低於高氣壓下進行蒸汽滅菌時的溶出物,及維持透明度與柔軟性,係由聚乙烯及聚丙烯等聚烯烴材料所構成。然而聚烯烴材料的透氧度極大。因此,為防止來自外界的氧氣使藥液變質,於專利文件1等已提案使用具有高氧氣屏障性的外包材包覆軟袋。外包材可舉出包含由金屬箔、無機沈積薄膜等所構成的層之外包材。Conventionally, a film used in a soft bag is made of a polyolefin material such as polyethylene or polypropylene in order to reduce the elution at the time of steam sterilization under high air pressure and to maintain transparency and flexibility. However, polyolefin materials have a high degree of oxygen permeability. Therefore, in order to prevent deterioration of the chemical liquid from the outside, it has been proposed to coat the soft bag with an outer covering material having a high oxygen barrier property, such as Patent Document 1. The outer covering material may include a coating material other than a layer composed of a metal foil, an inorganic deposited film, or the like.
然而胺基酸輸液或脂肪輸液等,因製劑及填充步驟中進行溶解、混合、懸濁、攪拌、藉由抽吸運送等,使空氣混入而以溶氧的形式殘留於藥液中。已知該溶氧濃度為3~50 ppm,且會促使藥液本身氧化劣化。氧化劣化的反應速度係隨著溫度以對數比例加快。亦即於高壓下進行蒸汽滅菌步驟時氧化劣化會急遽地增加。為防止發生上述狀況,至今實施有專利文件2、3等所提案之於輸液袋的外包裝上,內包或層合脫氧劑、使輸液袋的外包裝的內部充滿惰性氣體、將藥液以惰性氣體取代並同時進行填充、於藥液中添加抗氧化物質等方法。內包或層合脫氧劑、充滿惰性氣體等有助於抑制氧化劣化,但令人擔憂的是當具有屏障性的外包裝發生破損或穿刺有針孔時的錯誤投藥。進而前述先前技術之層合,由於使用以有機溶劑為媒介的乾式貼膜法,雖然符合日本藥典所規定的溶出試驗的範圍內,但不僅溶出物的量無法忽視,亦擔憂於貼膜步驟中異物混入被露出的層合界面。另外添加於藥液中的抗氧化物質可舉出維他命C(抗壞血酸)、維他命E(生育醇)、BHT(二丁基羥基甲苯)、BHA(丁基羥基甲氧苯)、異抗壞血酸鈉、亞硫酸鈉、二氧化硫、咖啡豆萃取物(綠原酸)、綠茶萃取物(兒茶素)、迷迭香萃取物等,由於其中以亞硫酸離子物質之抗氧化效果佳,而廣泛被使用為添加劑,但由於其為引起過敏性休克之原因,而不適用於人體。However, the amino acid infusion or the fat infusion or the like is dissolved, mixed, suspended, stirred, and transported by suction during the preparation and filling steps, and the air is mixed thereinto and remains as dissolved oxygen in the chemical solution. The dissolved oxygen concentration is known to be 3 to 50 ppm, and the oxidative degradation of the chemical solution itself is promoted. The reaction rate of oxidative degradation is accelerated in logarithmic scale with temperature. That is, oxidative degradation increases sharply when the steam sterilization step is performed under high pressure. In order to prevent the above-mentioned situation, the outer packaging of the infusion bag proposed by the patent documents 2, 3, etc. has been implemented, and the deoxidizer is contained or laminated, and the inside of the outer package of the infusion bag is filled with an inert gas, and the liquid medicine is used. A method in which an inert gas is substituted and simultaneously filled, and an antioxidant is added to the chemical solution. Inclusion or lamination of a deoxidizing agent, filling with an inert gas or the like contributes to suppression of oxidative degradation, but it is a concern that the barrier package is damaged or the needle is punctured. Further, in the lamination of the prior art, since the dry film method using an organic solvent as a medium is within the range of the dissolution test prescribed by the Japanese Pharmacopoeia, not only the amount of the eluted matter cannot be ignored, but also the foreign matter in the filming step is also feared. The exposed laminate interface. Further, the antioxidant added to the chemical solution may be vitamin C (ascorbic acid), vitamin E (tocopherol), BHT (dibutylhydroxytoluene), BHA (butylhydroxymethoxybenzene), sodium erythorbate or sodium sulfite. Sulfur dioxide, coffee bean extract (chlorogenic acid), green tea extract (catechin), rosemary extract, etc., are widely used as additives because of the excellent oxidation resistance of sulfite ionic substances. Because it is the cause of anaphylactic shock, it is not suitable for the human body.
由上述背景,下述之發明提案對於直接接觸醫療用藥液的容器本身,賦予氧屏障性或氧吸收功能。From the above background, the invention proposed below provides an oxygen barrier property or an oxygen absorbing function to the container itself which is in direct contact with the medical drug solution.
專利文件4係提案使用壓鑄共壓出法進行製膜之自外側依序為“聚醯胺或聚酯或聚烯烴之層”、“結合層”、“乙烯-乙烯醇共聚合物之核心層”、“結合層”、“聚烯烴之溶液接觸層”等5層構造體。該公報之構造體具有優異的氧屏障性,但不具有自體氧吸收功能。另外,由於進行壓鑄時採用使內面翻出的方式進行製膜,於軟袋的製膜步驟中會使溶液接觸面暴露至外界,而必須有異物混入袋內之對策。Patent Document 4 proposes to use a die-casting co-extrusion method to form a film from the outer side of the layer of "polyamide or polyester or polyolefin layer", "bonding layer", "core layer of ethylene-vinyl alcohol copolymer" A five-layer structure such as "bonding layer" or "solution contact layer of polyolefin". The structure of this publication has an excellent oxygen barrier property but does not have an autologous oxygen absorption function. Further, since the film is formed by the inner surface being turned out during the die casting, the solution contact surface is exposed to the outside in the film forming step of the soft bag, and countermeasures for foreign matter to be mixed into the bag are necessary.
專利文件5係提案使用共壓出法進行製膜之自外側依序至少為“乙烯-乙烯醇共聚合物所構成的氧屏障層”、“氧吸收性的氣體屏障a層”、“氧吸收性的氣體屏障b層”、“熱密封性樹脂層”之多層構造體。該公報於常溫環境下具有優異的氧屏障性及氧吸收性,但最外層的乙烯-乙烯醇共聚合物缺乏防溼性,會使需要在高壓下進行蒸汽滅菌等熱水處理之醫療用容器產生白化現象而不佳。Patent Document 5 proposes to use a co-extrusion method to form a film from the outer side at least "an oxygen barrier layer composed of an ethylene-vinyl alcohol copolymer," an "oxygen-absorbing gas barrier layer a", and an "oxygen absorption". A multilayer structure of a gas barrier b layer" and a "heat sealable resin layer". This publication has excellent oxygen barrier properties and oxygen absorption properties in a normal temperature environment, but the outermost ethylene-vinyl alcohol copolymer lacks moisture resistance, and a medical container that requires hot water treatment such as steam sterilization under high pressure. It is not good to produce whitening.
專利文件1:特開2005-280749號公報Patent Document 1: Special Publication No. 2005-280749
專利文件2:特開2009-154924號公報Patent Document 2: JP-A-2009-154924
專利文件3:特開2008-37065號公報Patent Document 3: JP-A-2008-37065
專利文件4:特開2009-22753號公報Patent Document 4: Special Open 2009-22753
專利文件5:特開2007-283565號公報Patent Document 5: JP-A-2007-283565
如前所述,以往為了防止因氧氣而使藥液氧化劣化的 包裝,存在如下所述之問題。該等問題可舉出例如外包裝破損或有針孔、由於使用有機溶劑造成該溶劑之溶出、因添加於藥液中的抗氧化劑而引起過敏性休克、因溶氧造成的氧化劣化、異物混入、防溼性不足及高壓蒸汽滅菌中產生白化現象。As described above, in the past, in order to prevent oxidative degradation of the chemical solution due to oxygen Packaging, there are problems as described below. Such problems include, for example, damage to the outer package or pinholes, dissolution of the solvent due to the use of an organic solvent, anaphylactic shock due to the antioxidant added to the chemical solution, oxidative degradation due to dissolved oxygen, and foreign matter incorporation. Whitening is caused by insufficient moisture resistance and high pressure steam sterilization.
為達成上述課題,本發明係採用下述手段。亦即,In order to achieve the above object, the present invention employs the following means. that is,
(1)本發明係一種具有氧吸收功能的醫療用容器用塑膠質薄膜,其係由碳數11以上的內醯胺開環聚合或碳數11以上的ω-胺基酸進行縮合聚合所得之聚醯胺,或由碳數10以上的二羧酸與碳數6以上的二胺進行共縮合聚合所得之聚醯胺所構成之第1層、與第1層鄰接,且以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物之第2層、與第2層鄰接,且以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之第3層、及以聚乙烯為主成分之密封層之至少4層所構成,且以共壓出的水冷式吹膜法進行製膜。(1) The present invention relates to a plastic film for a medical container having an oxygen absorbing function, which is obtained by condensation polymerization of an indoleamine having a carbon number of 11 or more, or an ω-amino acid having a carbon number of 11 or more. Polyamine or a first layer composed of a polyamidene obtained by co-condensation polymerization of a dicarboxylic acid having 10 or more carbon atoms and a diamine having 6 or more carbon atoms, adjacent to the first layer, and ethylene-vinyl alcohol a co-polymer as a main component, a second layer of a mixed composition having a polyene polymer having an unsaturated double bond and a transition metal salt as a subcomponent, adjacent to the second layer, and an α-olefin and an unsaturated carboxyl group a third layer of a copolymer of an anhydride of an acid or an unsaturated dicarboxylic acid as a main component, and at least four layers of a sealing layer containing a polyethylene as a main component, and is blown by a water-cooled type which is co-pressed. Membrane method is used for film formation.
(2)本發明係一種具有氧吸收功能的醫療用容器用塑膠質薄膜,其係由碳數11以上的內醯胺開環聚合或碳數11以上的ω-胺基酸進行縮合聚合所得之聚醯胺,或由碳數10以上的二羧酸與碳數6以上的二胺進行共縮合聚合所得之聚醯胺所構成之第1層、與第1層鄰接,且以α-烯烴與 不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之第2層、與第2層鄰接,以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物之第3層、與第3層鄰接,且以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之第4層、及以聚乙烯為主成分之密封層之至少5層所構成,且以共壓出的水冷式吹膜法進行製膜。(2) The present invention relates to a plastic film for a medical container having an oxygen absorbing function, which is obtained by condensation polymerization of an indoleamine having a carbon number of 11 or more or a ω-amino acid having a carbon number of 11 or more. Polyamide or a first layer composed of a polyamidene obtained by co-condensation polymerization of a dicarboxylic acid having 10 or more carbon atoms and a diamine having 6 or more carbon atoms, adjacent to the first layer, and an α-olefin and The copolymer of an unsaturated carboxylic acid or an anhydrous monomer of an unsaturated dicarboxylic acid is a second component of the main component, adjacent to the second layer, and has an ethylene-vinyl alcohol copolymer as a main component to have an unsaturated double The polyene polymer and the transition metal salt of the bond are the third layer of the mixed composition of the subcomponents, adjacent to the third layer, and the anhydrous monomer of the α-olefin and the unsaturated carboxylic acid or the unsaturated dicarboxylic acid. The fourth layer of the copolymer as a main component and at least five layers of a sealing layer mainly composed of polyethylene are formed by a water-cooling blown film method which is co-pressed.
(3)上述(1)或(2)項之醫療用容器用塑膠質薄膜,其中以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物之層,每1g可吸收30cc以上的氧氣,且該混合組成物之層的厚度為5~35%。(3) The plastic film for a medical container according to the above (1) or (2), wherein the ethylene-vinyl alcohol copolymer is a main component, and the polyene polymer having a unsaturated double bond and a transition metal salt are used. The layer of the mixed composition of the subcomponents can absorb 30 cc or more of oxygen per 1 g, and the thickness of the layer of the mixed composition is 5 to 35%.
(4)上述(1)~(3)項之醫療用容器用塑膠質薄膜,其中該第1層的融熔峰溫度為175℃以上,與該密封層的融熔峰溫度之差為40℃以上。(4) The plastic film for medical containers according to the above (1) to (3), wherein the melting temperature of the first layer is 175 ° C or higher, and the difference between the melting peak temperature of the sealing layer is 40 ° C the above.
(5)上述(1)或(2)項之塑膠質薄膜,其中該密封層係60~95質量%的線性低密度聚乙烯與5~40質量%的高密度聚乙烯之混合物。(5) The plastic film according to (1) or (2) above, wherein the sealing layer is a mixture of 60 to 95% by mass of linear low-density polyethylene and 5 to 40% by mass of high-density polyethylene.
(6)上述(1)~(3)項中任一項之塑膠質薄膜,其中該密封層係由與以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之該第4層鄰接之層,及鄰接於該層之高密度聚乙烯所形成之層此2層所構成。(6) The plastic film according to any one of the above items (1) to (3) wherein the sealing layer is a combination of an α-olefin and an unsaturated carboxylic acid or an unsaturated dicarboxylic acid. The polymer is composed mainly of the layer adjacent to the fourth layer and the layer formed of the high-density polyethylene adjacent to the layer.
(7)本發明係一種輸液袋,其係由如(1)~(6) 項中任一項之塑膠質薄膜所構成之輸液袋,且於本體上設置有注入口。(7) The present invention is an infusion bag, such as (1) to (6) The infusion bag formed of the plastic film of any one of the items, wherein the body is provided with an injection port.
根據本發明可提供於吸收藥液中的溶氧的同時,具有優異的阻止外界侵入的氧氣之屏障性,且具有優異的符合日本藥典所規定的安全衛生性,以高溫且短時間的熱密封膜可容易的進行製袋,於薄膜層間混入來自外界異物的可能性極低,以及具有可對應121℃高壓蒸汽滅菌之耐熱性、透明性、柔軟性及耐衝擊強度之塑膠質薄膜。另外,由本發明之塑膠質薄膜製造之輸液袋,具備前述之特徵。According to the present invention, it is possible to provide a barrier to oxygen which is excellent in preventing intrusion of the outside while absorbing oxygen dissolved in the chemical solution, and has excellent safety and hygienic properties in accordance with the Japanese Pharmacopoeia, and is heat sealed at a high temperature for a short period of time. The film can be easily formed into a bag, and the possibility of mixing foreign matter from the outside of the film layer is extremely low, and a plastic film having heat resistance, transparency, flexibility, and impact strength comparable to 121 ° C high-pressure steam sterilization can be obtained. Further, the infusion bag manufactured from the plastic film of the present invention has the above-described features.
以下針對本發明更詳細地加以說明。The invention is described in more detail below.
本發明第1個實施方式之塑膠質薄膜其一例的層構成係如圖1所示。該薄膜自上而下必須具備由第1層1、第2層2、第3層3及密封層4所構成的4層。The layer structure of an example of the plastic film according to the first embodiment of the present invention is as shown in Fig. 1 . The film must have four layers composed of the first layer 1, the second layer 2, the third layer 3, and the sealing layer 4 from top to bottom.
第1層1(以下稱作最外層)係由碳數11以上的內醯胺開環聚合或碳數11以上的ω-胺基酸進行縮合聚合所得之聚醯胺,或由碳數10以上的二羧酸與碳數6以上的二胺進行共縮合聚合所得之聚醯胺所構成之層。第2層2(以下稱作氧吸收層)係與第1層1鄰接,且以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物之層。第3層3(以下稱作層間接著層)係與第2層2鄰接,且以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之層。密封 層4係以聚乙烯為主成分之層。The first layer 1 (hereinafter referred to as the outermost layer) is a polydecylamine obtained by ring-opening polymerization of an indoleamine having a carbon number of 11 or more or a ω-amino acid having a carbon number of 11 or more, or a carbon number of 10 or more. A layer composed of a polydecylamine obtained by co-condensation polymerization of a dicarboxylic acid and a diamine having 6 or more carbon atoms. The second layer 2 (hereinafter referred to as an oxygen absorbing layer) is adjacent to the first layer 1, and has an ethylene-vinyl alcohol copolymer as a main component, and a polyene polymer having an unsaturated double bond and a transition metal salt. A layer of a mixture of subcomponents. The third layer 3 (hereinafter referred to as an interlayer adhesion layer) is a layer mainly composed of a copolymer of an α-olefin and an anhydrous monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid, which is adjacent to the second layer 2 and mainly composed of a copolymer of an α-olefin and an unsaturated carboxylic acid. . seal Layer 4 is a layer mainly composed of polyethylene.
該最外層係於進行熱接著之製袋步驟中裝上稱作注射座(port)之藥液的排出與注入口部品時,因外部加熱引起薄膜損傷的緩衝層。第1層1係由碳數11以上的內醯胺開環聚合或碳數11以上的ω-胺基酸進行縮合聚合所得之聚醯胺所構成。另外,第1層1係由碳數10以上的二羧酸與碳數6以上的二胺進行共縮合聚合所得之聚醯胺所構成。The outermost layer is a buffer layer which is damaged by external heating when the discharge of the chemical liquid called the injection port and the injection port part are carried out in the step of performing the heat-sealing process. The first layer 1 is composed of a polydecylamine obtained by ring-opening polymerization of an indoleamine having a carbon number of 11 or more or a ω-amino acid having a carbon number of 11 or more. Further, the first layer 1 is composed of a polydecylamine obtained by co-condensation polymerization of a dicarboxylic acid having 10 or more carbon atoms and a diamine having 6 or more carbon atoms.
使其進行開環聚合之內醯胺之碳數為11以上,且碳數上限為12。內醯胺單體之碳數未達11時,於高溫下使用易產生聚醯胺的去重合反應,作為醫療容器不僅未符合規定的溶出試驗的規格,且因吸濕性增高,在高溫下進行蒸汽滅菌時易引起白化而不佳。The carbon number of the indoleamine which is subjected to ring-opening polymerization is 11 or more, and the upper limit of the carbon number is 12. When the carbon number of the mesaconamine monomer is less than 11, the de-cohesion reaction which is easy to produce polyamine is used at a high temperature, and the medical container not only fails to meet the specifications of the predetermined dissolution test, but also has a high hygroscopicity at a high temperature. It is easy to cause whitening when steam sterilization.
內醯胺可舉出例如十一烷內醯胺、十二碳內醯胺等。開環聚合的方法係周知之聚醯胺的製法,亦有市售品。使十一烷內醯胺進行開環聚合可得尼龍11,使十二碳內醯胺進行開環聚合可得尼龍12。The mesalamine may, for example, be undecane decylamine or dodecyl decylamine. The ring-opening polymerization method is a well-known method for producing polyamine, and there are also commercially available products. Nylon 11 can be obtained by ring-opening polymerization of undecane indoleamine, and ring-opening polymerization of dodecyl decylamine can be carried out to obtain nylon 12.
使ω-胺基酸進行縮合聚合時碳數為11以上,且碳數上限為12。碳數未達11時,與採用內醯胺開環聚合所得之聚醯胺有相同的問題。ω-胺基酸可舉出ω-胺基十一烷酸、ω-胺基十二烷酸等。縮合聚合的方法係周知之聚醯胺的製法,亦有市售品。When the ω-amino acid is subjected to condensation polymerization, the carbon number is 11 or more, and the upper limit of the carbon number is 12. When the carbon number is less than 11, the same problem as the polyamine which is obtained by ring-opening polymerization of indoleamine is the same. Examples of the ω-amino acid include ω-aminoundecanoic acid and ω-aminododecanoic acid. The method of condensation polymerization is a well-known method for producing polyamine, and there are also commercially available products.
使二羧酸與二胺進行共縮合聚合時之二羧酸,碳數為10以上,且碳數上限為12。二羧酸可舉出癸二酸、十二烷二酸等。二胺係碳數6以上。二胺可舉出己二胺等。共縮 合聚合的方法係周知之聚醯胺的製法,亦有市售品。使癸二酸與己二胺進行共縮合聚合可得尼龍610,使十二烷二酸與己二胺進行共縮合聚合可得尼龍612。The dicarboxylic acid in the case of co-condensation polymerization of a dicarboxylic acid and a diamine has a carbon number of 10 or more and an upper limit of carbon number of 12. Examples of the dicarboxylic acid include sebacic acid, dodecanedioic acid, and the like. The diamine has a carbon number of 6 or more. The diamine may, for example, be hexamethylenediamine or the like. Co-shrink The method of polymerization is a well-known method for producing polyamine, and there are also commercially available products. Nylon 610 can be obtained by co-condensation polymerization of sebacic acid with hexamethylenediamine, and nylon 612 can be obtained by co-condensation polymerization of dodecanedioic acid and hexamethylenediamine.
以該三種方法之任一種所獲得之聚醯胺,可單獨使用,亦可以任意的比例混合。The polyamine obtained by any of the three methods may be used singly or in any ratio.
使用之聚醯胺的融熔峰溫度為175℃以上為佳,175℃~245℃更佳,175℃~230℃最佳。該融熔峰的測定方法係使用微差掃描熱量計:DSC,以JIS-K7121為基準進行測定。The melting peak temperature of the polyamine used is preferably 175 ° C or higher, more preferably 175 ° C to 245 ° C, and most preferably 175 ° C to 230 ° C. The measurement method of this melting peak was measured using a differential scanning calorimeter: DSC based on JIS-K7121.
第1層1之厚度相對於總厚度以2~15%為佳,2~10%更佳。2~8%最佳。第1層1之厚度未達2%時,密封時無法充分發揮對因傳熱造成的損害的緩衝果,而第1層1之厚度超過15%時,多層薄膜的剛性會顯著增加,而損及醫療用容器的柔軟度。The thickness of the first layer 1 is preferably 2 to 15% with respect to the total thickness, and more preferably 2 to 10%. 2~8% is the best. When the thickness of the first layer 1 is less than 2%, the cushioning fruit for damage due to heat transfer cannot be sufficiently exhibited at the time of sealing, and when the thickness of the first layer 1 exceeds 15%, the rigidity of the multilayer film is remarkably increased, and the damage is increased. And the softness of the medical container.
第2層2係氧吸收層,以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物。The second layer 2 type oxygen absorbing layer is a mixed composition containing an ethylene-vinyl alcohol copolymer as a main component and a polyene polymer having an unsaturated double bond and a transition metal salt as a subcomponent.
以乙烯-乙烯醇共聚合物為主成分,且乙烯含量為25~45莫耳%為佳,27~44莫耳%更佳。The ethylene-vinyl alcohol copolymer is mainly composed, and the ethylene content is preferably 25 to 45 mol%, more preferably 27 to 44 mol%.
作為副成分之具有不飽和雙鍵之多烯系聚合體,係以雙鍵數為2以上之烴為單位的聚合物。以共軛二烯聚合物為佳,例如可舉出直鏈狀共軛二烯之cis-或trans-1,4-異戊二烯聚合物之聚異戊二烯、聚異戊二烯藉由周環反應而得之含有環化聚異戊二烯之聚異戊二烯,以及直鏈狀共軛二烯之1,3-丁二烯聚合物之聚丁二烯、聚丁二烯藉由周環反應而得之含有環化聚丁二烯之聚丁二烯等之直鏈狀聚合物以及環狀聚合物。多烯系聚合物之含量以20~40質量%為佳,25~35質量%更佳。The polyene polymer having an unsaturated double bond as an accessory component is a polymer having a hydrocarbon having 2 or more double bonds. The conjugated diene polymer is preferred, and examples thereof include polyisoprene or polyisoprene which are cis- or trans-1,4-isoprene polymers of a linear conjugated diene. a polybutadiene containing a cyclic polyisoprene and a polybutadiene of a 1,3-butadiene polymer of a linear conjugated diene obtained by a cyclic reaction A linear polymer such as polybutadiene containing a cyclized polybutadiene and a cyclic polymer obtained by a cyclic reaction. The content of the polyene polymer is preferably from 20 to 40% by mass, more preferably from 25 to 35% by mass.
副成分之遷移金屬鹽可舉出例如鐵、鎳、銅、錳、鈷、銠、鈦、鉻、釩、釕等之鹽。適合形成鹽的酸為有機酸,特別以單羧酸為佳,例如硬酯酸、新癸酸等。較佳的遷移金屬鹽可舉出例如硬酯酸鈷、新癸酸鈷。遷移金屬鹽含量以50~500ppm為佳,100~300ppm更佳。The transition metal salt of the accessory component may, for example, be a salt of iron, nickel, copper, manganese, cobalt, rhodium, titanium, chromium, vanadium or ruthenium. The acid suitable for forming a salt is an organic acid, particularly preferably a monocarboxylic acid such as stearic acid, neodecanoic acid or the like. Preferred examples of the transition metal salt include cobalt stearate and cobalt neodecanoate. The content of the migration metal salt is preferably from 50 to 500 ppm, more preferably from 100 to 300 ppm.
與作為主成分之乙烯-乙烯醇共聚合物混合之多烯系聚合物以及遷移金屬鹽,係藉由以遷移金屬鹽作為觸媒而進行之多烯系聚合物之氧化斷裂反應,生成醇、醛、酮、羧酸的同時吸收氧。本發明中混合物之組成,係以含有每1g可吸收30cc以上的氧氣之共軛二烯成分為佳。第2層2之厚度以塑膠質薄膜的總厚度之5~35%為佳,10~30%更佳。第2層2的厚度未達總厚度之5%時,氧吸收能力變為不充分。反之,第2層2之厚度超過35%時,會具有所需份量以上之吸收氧能力。進而,由於會損及薄膜的物性強度,同時造成製造成本不必要的提高而不佳。The polyene polymer and the transition metal salt mixed with the ethylene-vinyl alcohol copolymer as a main component are oxidative cleavage reaction of the polyene polymer by using a migrating metal salt as a catalyst to form an alcohol. The aldehyde, ketone, and carboxylic acid simultaneously absorb oxygen. The composition of the mixture in the present invention is preferably a conjugated diene component containing 1 gram of oxygen which can absorb 30 cc or more. The thickness of the second layer 2 is preferably 5 to 35% of the total thickness of the plastic film, and more preferably 10 to 30%. When the thickness of the second layer 2 is less than 5% of the total thickness, the oxygen absorbing ability is insufficient. On the other hand, when the thickness of the second layer 2 exceeds 35%, it has a desired oxygen absorption capacity or more. Further, the physical strength of the film is impaired, and the manufacturing cost is unnecessarily increased.
具有氧吸收功能的混合組成物,市售品可使用Kuraray股份有限公司製之「PROACT」,及日本Zeon股份有限公司製之「QUINTIA」等。For the mixed composition having an oxygen absorbing function, "PROACT" manufactured by Kuraray Co., Ltd., "QUINTIA" manufactured by Zeon Co., Ltd., and the like can be used as a commercial product.
第3層3係第2層2及後述之密封層4之間,具有防濕性的層間接著層,以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分。A third layer 3, a second layer 2, and a sealing layer 4 to be described later, having a moisture-proof interlayer, a copolymerization of an α-olefin with an unsaturated monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid The main component.
α-烯烴係可舉出乙烯或丙烯等。單獨乙烯或丙烯等或為聚合物之聚烯烴,可藉由使用自遷移金屬化合物與有機鋁化合物所得之觸媒計(戚格勒觸媒)、或藉由使單體(例如二氧化矽)擔載鉻化合物(例如氧化鉻)所得之觸媒計(菲利浦觸媒)、或是使用自由基起始劑(例如有機過氧化物)之烯烴進行單獨聚合或共聚合而獲得。The α-olefin system may, for example, be ethylene or propylene. A polyolefin which is ethylene or propylene alone or in a polymer, which can be obtained by using a catalyst unit obtained from a self-migrating metal compound and an organoaluminum compound, or by a monomer such as cerium oxide. It is obtained by separately polymerizing or copolymerizing a catalyst meter (Philipn catalyst) obtained by supporting a chromium compound (for example, chromium oxide) or an olefin using a radical initiator (for example, an organic peroxide).
另外,本發明中所使用之不飽和羧酸或不飽和二羧酸之無水物單體係指含有具有至少一個雙鍵,且具有至少一個羧基或其無水物(基)之化合物,可舉出(甲基)丙烯酸、馬來酸、富馬酸、馬來酸酐、富馬酸酐、衣康酸、焦檸檬酸、納迪克酸、衣康酸酐、納迪克酸酐、焦檸檬酸酐等。Further, the anhydrous monohydrate system of the unsaturated carboxylic acid or the unsaturated dicarboxylic acid used in the present invention means a compound containing at least one double bond and having at least one carboxyl group or an anhydride thereof, and exemplified (Meth)acrylic acid, maleic acid, fumaric acid, maleic anhydride, fumaric anhydride, itaconic acid, pyrocitric acid, nadic acid, itaconic anhydride, nadic anhydride, pyroguanic anhydride, and the like.
第3層3所使用之α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物係指前述之聚烯烴的不飽和單體的接枝共聚合物。接枝共聚合係藉由將100質量份之聚烯烴中添加不飽和單體0.01~20質量份、有機過氧化物0.001~20質量份所得之混合物,供給予壓出機,使其進行熔融反應後可得。The copolymer of the α-olefin used in the third layer 3 and the anhydrous monomer of the unsaturated carboxylic acid or the unsaturated dicarboxylic acid means a graft copolymer of the above-mentioned unsaturated monomer of the polyolefin. The graft copolymerization is carried out by adding a mixture of 0.01 to 20 parts by mass of an unsaturated monomer to 0.001 to 20 parts by mass of an organic peroxide to 100 parts by mass of the polyolefin, and supplying it to an extruder to carry out a melting reaction. Available later.
本發明中所使用之有機過氧化物可舉出代表例為過氧苯甲酸三級丁酯、2,5-二甲基-2,5-二(過氧三級丁基)己烷、二過氧化三級丁醇。該等有機過氧化物中,以一分鐘半衰期為100~280℃之有機過氧化物為佳,適用120~230℃之有機過氧化物。該等有機過氧化物可單獨使用,亦可併用2種以上。The organic peroxide used in the present invention may, for example, be a tertiary butyl peroxybenzoate or a 2,5-dimethyl-2,5-di(peroxytributyl)hexane or two. Tertiary butanol peroxide. Among these organic peroxides, an organic peroxide having a one-minute half-life of 100 to 280 ° C is preferred, and an organic peroxide of 120 to 230 ° C is suitable. These organic peroxides may be used singly or in combination of two or more.
相對於100質量份之聚烯烴,不飽和羧酸或不飽和二羧酸之無水物單體的混合未達0.01質量份時,所得之共聚合物與乙烯-乙烯醇共聚合物以及後述之聚醯胺會出現缺乏接著性。反之超過20質量份時,由於接枝反應效率降低,不僅於接枝反應中大量殘留未反應或單獨聚合的不飽和化合物,亦損及聚烯烴原有的物性。When the mixing of the unsaturated carboxylic acid or the anhydrous monomer of the unsaturated dicarboxylic acid is less than 0.01 parts by mass with respect to 100 parts by mass of the polyolefin, the obtained copolymer and the ethylene-vinyl alcohol copolymer and the polymerization described later Indoleamine may be deficient in adhesion. On the other hand, when it exceeds 20 parts by mass, the graft reaction efficiency is lowered, and not only a large amount of unreacted or separately polymerized unsaturated compound remains in the graft reaction, but also the original physical properties of the polyolefin are impaired.
相對於100質量份之聚烯烴,有機過氧化物的混合未達0.001質量份時,無法獲得目標的接枝共聚合物。反之超過20質量份時會損及聚烯烴原有的物性。When the mixing of the organic peroxide is less than 0.001 part by mass with respect to 100 parts by mass of the polyolefin, the intended graft copolymer cannot be obtained. On the other hand, when it exceeds 20 parts by mass, the original physical properties of the polyolefin are impaired.
將上述之混合物投入一般使用之壓出機,於其內部進行熔融混練的同時,亦進行接枝反應,藉此獲得接枝改性物。此時使用之壓出機可為無帶式及帶式任一種,但自去除未反應或單獨聚合的不飽和物以及有機過氧化物的分解物之觀點而言,以帶式壓出機為佳。進而混練溫度為230~300℃,依使用之聚烯烴及有機過氧化物而異,但以230~250℃為佳。另外於壓出機內混合物的滯留時間為60秒以上,特別以90秒以上為佳。混練溫度未達230℃時,接枝反應無法順利進行。反之超過300℃時,一部份聚烯烴會開始產生劣化。另外壓出機內混合物的滯留時間未達60秒時,無法進行目標之接枝反應。The above mixture is put into a press machine which is generally used, and melt-kneading is carried out inside, and a graft reaction is also carried out, whereby a graft modified product is obtained. The extruder used at this time may be either a beltless belt or a belt type, but from the viewpoint of removing unreacted or separately polymerized unsaturated materials and decomposition products of organic peroxides, the belt extruder is good. Further, the kneading temperature is 230 to 300 ° C, depending on the polyolefin to be used and the organic peroxide, but it is preferably 230 to 250 ° C. Further, the residence time of the mixture in the extruder is 60 seconds or longer, and particularly preferably 90 seconds or longer. When the mixing temperature was less than 230 ° C, the grafting reaction could not proceed smoothly. On the contrary, when it exceeds 300 ° C, a part of the polyolefin will start to deteriorate. Further, when the residence time of the mixture in the extruder was less than 60 seconds, the target graft reaction could not be performed.
目前α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物有市售品,亦可利用該等市售品。At present, a copolymer of an α-olefin and an anhydrous monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid is commercially available, and such commercially available products can also be used.
第3層3可單獨使用上述之共聚合物,亦可使用共聚合物與聚烯烴之混合組成物。使用後者之情況下,於同一溫度下共聚合物的熔融黏度與聚烯烴的熔融黏度之比η(聚烯烴)/η(共聚合物)以2.0以上為佳。未達2.0時由於共聚合物與聚烯烴有均勻地微分散之傾向,使存在於乙烯-乙烯醇共聚合物以及後述之聚醯胺之界面的極性基被稀釋,而出現接著力降低之傾向。As the third layer 3, the above-mentioned copolymer may be used singly, and a mixed composition of a copolymer and a polyolefin may also be used. In the case of the latter, the ratio η (polyolefin) / η (copolymer) of the melt viscosity of the copolymer at the same temperature to the melt viscosity of the polyolefin is preferably 2.0 or more. When it is less than 2.0, since the copolymer and the polyolefin have a tendency to be uniformly finely dispersed, the polar group present at the interface between the ethylene-vinyl alcohol copolymer and the polyamine described later is diluted, and the tendency of the adhesion is lowered. .
第3層3係以上述之α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成份之層,構成第3層3的全量亦可由該共聚合物所成。另一方面,亦可含有其他樹脂。此時會減低接著強度,但依專利申請人進行的實驗結果,以50%共聚合物與50%聚乙烯之混合物亦可形成第3層3。The third layer 3 is a layer mainly composed of a copolymer of the above α-olefin and an unsaturated monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid, and the total amount of the third layer 3 may be composed of the copolymer. Made into. On the other hand, other resins may also be contained. The subsequent strength is reduced at this time, but according to the experimental results of the patent applicant, the third layer 3 can also be formed with a mixture of 50% copolymer and 50% polyethylene.
第3層3之厚度以塑膠質薄膜的總厚度之2~15%為佳,2~10%更佳。第3層3的厚度未達2%時,乙烯-乙烯醇共聚合物及後述之聚醯胺的接著變為不充分,第3層3之厚度超過15%時,會損及薄膜的物性強度,同時使造成製造成本不必要的提高而不佳。The thickness of the third layer 3 is preferably 2 to 15% of the total thickness of the plastic film, and more preferably 2 to 10%. When the thickness of the third layer 3 is less than 2%, the ethylene-vinyl alcohol copolymer and the polyamine described later are insufficiently formed. When the thickness of the third layer 3 exceeds 15%, the physical strength of the film is impaired. At the same time, it is not good to make the manufacturing cost unnecessary.
本發明中密封層4係指鄰接於以聚乙烯為主成份之第3層3的內側之層,可為單層或多層。密封層4之例可舉出低密度聚乙烯,高密度聚乙烯,線性低密度聚乙烯,亦可為該等單體組成之混合組成。該等聚乙烯中,特別以具優異透明性及柔軟性、耐撞擊性之線性低密度聚乙烯60~95質量%,與具優異耐熱性之高密度聚乙烯5~40質量%的混合物具有互補的物性而為佳。In the present invention, the sealing layer 4 refers to a layer adjacent to the inner side of the third layer 3 mainly composed of polyethylene, and may be a single layer or a plurality of layers. Examples of the sealing layer 4 include low density polyethylene, high density polyethylene, linear low density polyethylene, and a mixed composition of the monomers. Among these polyethylenes, 60 to 95% by mass of linear low-density polyethylene having excellent transparency, flexibility, and impact resistance is complementary to a mixture of 5 to 40% by mass of high-density polyethylene having excellent heat resistance. The physical properties are better.
本發明中之線性低密度聚乙烯係指選自乙烯與碳數為3~20的α-烯烴之一種以上的α-烯烴之共聚合物。碳數為3~20的α-烯烴中以碳數為3~12個的α-烯烴為佳。具體可舉出丁烯、1-丁烯、1-戊烯、4-甲基-1-戊烯、1-己烯、1-辛烯、1-癸烯及1-十一烯等,以丁烯、1-丁烯、1-己烯、1-辛烯為佳。共聚合物佔α-烯烴中之含量一般為1~30莫耳%,3~20莫耳%為佳。另外線性低密度乙烯可使用根據JIS-K7112-D其密度為0.900~0.940g/cm3 ,且依據JIS-K7210為準,於溫度為190℃,荷重21.18N條件下所測定之融熔指數(MFR)為0.1~20g/10分鐘的線性低密度聚乙烯為佳。The linear low-density polyethylene in the present invention means a copolymer of one or more α-olefins selected from the group consisting of ethylene and an α-olefin having 3 to 20 carbon atoms. Among the α-olefins having 3 to 20 carbon atoms, α-olefins having 3 to 12 carbon atoms are preferred. Specific examples thereof include butene, 1-butene, 1-pentene, 4-methyl-1-pentene, 1-hexene, 1-octene, 1-decene, and 1-undecene. Butylene, 1-butene, 1-hexene, 1-octene are preferred. The content of the copolymer in the α-olefin is generally from 1 to 30 mol%, preferably from 3 to 20 mol%. Further, the linear low-density ethylene may be a melt index measured according to JIS-K7112-D having a density of 0.900 to 0.940 g/cm 3 and based on JIS-K7210 at a temperature of 190 ° C and a load of 21.18 N ( MFR) is preferably a linear low density polyethylene of 0.1 to 20 g/10 minutes.
本發明中高密度乙烯係密度0.940~0.970g/cm3 ,MFR為0.1~20g/10分鐘的高密度聚乙烯為佳。密度及MFR的測定條件與線性低密度乙烯相同。In the present invention, a high-density polyethylene having a density of 0.940 to 0.970 g/cm 3 and an MFR of 0.1 to 20 g/10 minutes is preferred. Density and MFR were measured under the same conditions as linear low density ethylene.
另外為提升透明性及耐熱性,亦可於密封層4之聚乙烯中添加結晶造核劑。適合的結晶造核劑可舉出例如環己烷二羧酸鈣鹽,以及硬酯酸鋅的混合物,有效量為可使該核劑以佔密封層全質量之2.5質量%以下之量混合於密封層4。核劑添加量的下限為約0.5質量%。Further, in order to improve transparency and heat resistance, a crystal nucleating agent may be added to the polyethylene of the sealing layer 4. Suitable crystal nucleating agents include, for example, a calcium salt of cyclohexanedicarboxylate and a mixture of zinc stearate. The effective amount is such that the nucleating agent can be mixed in an amount of 2.5% by mass or less based on the total mass of the sealing layer. Sealing layer 4. The lower limit of the amount of the nucleating agent added is about 0.5% by mass.
密封層4的融熔峰溫度為第1層1的融熔峰溫度以下,第1層1的融熔峰溫度與密封層4的融熔峰溫度之差為40℃以上為佳,45℃以上更佳。該溫度差未達40℃時,容易受到因熱密封所帶來的損害而不佳。並未特別限定融熔峰溫度差的上限,通常至100℃為止。第1層1與密封層4的熔點 差過大時,進行共壓出時由於密封層4亦採用高溫製膜,密封層4的熔融黏度顯著降低,無法安定地進行製膜。The melting peak temperature of the sealing layer 4 is equal to or lower than the melting peak temperature of the first layer 1, and the difference between the melting peak temperature of the first layer 1 and the melting peak temperature of the sealing layer 4 is preferably 40 ° C or more, and 45 ° C or more. Better. When the temperature difference is less than 40 ° C, it is liable to be damaged by heat sealing. The upper limit of the temperature difference of the melting peak is not particularly limited, and is usually up to 100 °C. Melting point of the first layer 1 and the sealing layer 4 When the difference is too large, when the sealing layer 4 is also formed at a high temperature during the co-extrusion, the melt viscosity of the sealing layer 4 is remarkably lowered, and film formation cannot be performed stably.
密封層4之厚度以塑膠質薄膜的總厚度之30~89%為佳,35~85%亦佳,35~80%最佳。密封層4的厚度未達30%時,會損及薄膜的物性強度,超過89%時,前述之第1~3層的厚度會變為不充分。The thickness of the sealing layer 4 is preferably 30 to 89% of the total thickness of the plastic film, 35 to 85%, and 35 to 80%. When the thickness of the sealing layer 4 is less than 30%, the physical strength of the film is impaired, and when it exceeds 89%, the thickness of the first to third layers described above is insufficient.
本發明中塑膠質薄膜,依據第十五回改訂日本藥典第一部一般試驗法塑膠製醫藥品容器試驗法所規定之各試驗項目的所有實測值,均符合聚乙烯製或聚丙烯製水性注射容器之規格。According to the fifteenth time, all the measured values of the test items specified in the first general test method of the plastic medicine container test method of the Japanese Pharmacopoeia are in accordance with the polyethylene or polypropylene water-based injection. The size of the container.
第1實施方式之塑膠質薄膜其變形例的層構造係如圖2所示。該薄膜自上而下係由第1層1、第2層2、第3層3及保持透明性及柔軟性的密封層41以及鄰接於密封層41之直接熔融密封層42所構成的5層構造。The layer structure of the modified example of the plastic film of the first embodiment is as shown in FIG. 2 . The film is composed of a first layer 1, a second layer 2, a third layer 3, and a sealing layer 41 for maintaining transparency and flexibility, and a layer 5 of a direct fusion sealing layer 42 adjacent to the sealing layer 41 from top to bottom. structure.
該密封層為2層時,使密封層41為主要之層為佳,更具體而言,使與第3層鄰接之密封層41與直接熔融密封層42的厚度比,範圍設定於50~97:50~3為佳,70~95:30~5更佳。When the sealing layer is two layers, it is preferable that the sealing layer 41 is a main layer, and more specifically, the thickness ratio of the sealing layer 41 adjacent to the third layer to the direct molten sealing layer 42 is set to 50 to 97. : 50~3 is better, 70~95:30~5 is better.
具體所使用的密封層樹脂係使與第3層鄰接之密封層41,為線性低密度聚乙烯60~95質量%及高密度聚乙烯5~40質量%之混合物,且直接熔融密封層42為僅由高密度聚乙烯所構成之層。藉由形成該等層,可確實防止高壓蒸汽滅菌後相鄰的薄膜表面的一部份會黏著而結塊。Specifically, the sealing layer resin used is a sealing layer 41 adjacent to the third layer, which is a mixture of linear low-density polyethylene of 60 to 95% by mass and high-density polyethylene of 5 to 40% by mass, and the direct molten sealing layer 42 is A layer consisting only of high density polyethylene. By forming the layers, it is possible to surely prevent a portion of the adjacent film surface from sticking and agglomerating after autoclaving.
本發明的第2實施方式之塑膠質薄膜其一例之層構成 如圖3所示。該薄膜自上而下係由第1層1、第2層31、第3層2、第4層32及密封層4所構成的5層構造。本發明之塑膠質薄膜的第2實施方式,第1層1(最外層)係由碳數11以上的內醯胺開環聚合或碳數11以上的ω-胺基酸進行縮合聚合所得之聚醯胺,或由碳數10以上的二羧酸與碳數6以上的二胺進行共縮合聚合所得之聚醯胺所構成之層。第2層31(第1層間接著層)係與該第1層鄰接,且以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之層。第3層2(氧吸收層)係與該第2層鄰接,且以乙烯-乙烯醇共聚合物為主成分,以具有不飽和雙鍵之多烯系聚合體及遷移金屬鹽為副成分之混合組成物之層。第4層32(第2層間接著層)係與該第3層鄰接,且以α-烯烴與不飽和羧酸或不飽和二羧酸之無水物單體的共聚合物為主成分之層。密封層4係以聚乙烯為主成份之層。A layered structure of an example of a plastic film according to a second embodiment of the present invention As shown in Figure 3. The film has a five-layer structure composed of the first layer 1, the second layer 31, the third layer 2, the fourth layer 32, and the sealing layer 4 from top to bottom. In the second embodiment of the plastic film of the present invention, the first layer 1 (outermost layer) is obtained by condensation polymerization of an indole amine having a carbon number of 11 or more or a ω-amino acid having a carbon number of 11 or more. A layer composed of polyamine which is obtained by co-condensation polymerization of a dicarboxylic acid having 10 or more carbon atoms and a diamine having 6 or more carbon atoms. The second layer 31 (the first interlayer adhesive layer) is a layer mainly composed of a copolymer of an α-olefin and an unsaturated monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid, which is adjacent to the first layer. The third layer 2 (oxygen absorbing layer) is adjacent to the second layer, and has an ethylene-vinyl alcohol copolymer as a main component, and a polyene polymer having an unsaturated double bond and a transition metal salt as a subcomponent. Mix the layers of the composition. The fourth layer 32 (the second interlayer adhesive layer) is a layer mainly composed of a copolymer of an α-olefin and an anhydrous monomer of an unsaturated carboxylic acid or an unsaturated dicarboxylic acid, which is adjacent to the third layer. The sealing layer 4 is a layer mainly composed of polyethylene.
該等層之內、最外層、氧吸收層、第1、第2層間接著層及密封層(除層厚以外)的說明係與上述第1實施方式之最外層、氧吸收層、層間接著層及密封層相同。密封層的層厚以總層之30~89%為佳,35~85%更佳。The innermost layer, the outermost layer, the oxygen absorbing layer, the first and second interlayers, and the sealing layer (excluding the layer thickness) of the layers are the outermost layer, the oxygen absorbing layer, and the interlayer between the layers of the first embodiment. And the sealing layer is the same. The layer thickness of the sealing layer is preferably from 30 to 89% of the total layer, and more preferably from 35 to 85%.
亦即,第1實施方式之塑膠質薄膜與第2實施方式之塑膠質薄膜之差異在於最外層與氧吸收層間亦設置有具防溼性的層間接著層。藉由配置該接著層,可抑制因高壓蒸汽滅菌步驟造成的氧吸收層吸溼後白化之情況。In other words, the plastic film of the first embodiment differs from the plastic film of the second embodiment in that an interlayer sealing layer having moisture resistance is provided between the outermost layer and the oxygen absorbing layer. By arranging the adhesive layer, it is possible to suppress the whitening of the oxygen absorbing layer due to the high pressure steam sterilization step after moisture absorption.
並未特別限制本發明薄膜的總厚度,但考量透明性、柔軟性、耐撞擊性、水蒸氣通透性等之後,於第1實施方 式與第2實施方式任一項均以50~1000μm之範圍為佳,100~350μm更佳,150~250μm特佳。The total thickness of the film of the present invention is not particularly limited, but after considering transparency, flexibility, impact resistance, water vapor permeability, etc., in the first embodiment Both the formula and the second embodiment are preferably in the range of 50 to 1000 μm, more preferably 100 to 350 μm, and particularly preferably 150 to 250 μm.
第2實施方式之塑膠質薄膜另一例之層構成如圖4所示。該薄膜自上而下係具備第1層1(最外層)、第2層(第1層間接著層)31、第3層(氧吸收層)2、第4層(第2層間接著層)32、第5層(保持透明性及柔軟性之密封層)41及第6層(直接熔融密封層)42所構成的6層。The layer structure of another example of the plastic film of the second embodiment is shown in Fig. 4 . The film includes a first layer 1 (outermost layer), a second layer (first layer interlayer) 31, a third layer (oxygen absorbing layer) 2, and a fourth layer (second interlayer layer) 32 from top to bottom. Six layers of the fifth layer (sealing layer for maintaining transparency and flexibility) 41 and the sixth layer (direct sealing layer) 42 are formed.
使用本發明之塑膠質薄膜製做之本發明的輸液袋之一例係示於圖5。An example of the infusion bag of the present invention made using the plastic film of the present invention is shown in Fig. 5.
該輸液袋係由管狀的塑膠質薄膜10所構成之輸液袋的第1端,設置注入口11後進行熱密封,再以該第1端熱密封部12為底部後,自輸液收納部13填充輸液後,於第2端進行熱密封而成。於第2端熱密封部14之中央,穿洞形成懸吊孔15,再於其兩側設置長方形的未密封部16。設置注入口11的前端設置有可插入注射針之橡膠拴。另外注入口亦可為管狀。The infusion bag is a first end of an infusion bag composed of a tubular plastic film 10, and is provided with an injection port 11 and then heat-sealed, and the first end heat sealing portion 12 is used as a bottom portion, and then filled from the infusion storage portion 13 After infusion, it is heat sealed at the second end. In the center of the second end heat sealing portion 14, a hole is formed through the hole to form a hanging hole 15, and a rectangular unsealed portion 16 is provided on both sides thereof. The front end of the injection port 11 is provided with a rubber crucible into which an injection needle can be inserted. In addition, the injection port can also be tubular.
本發明之塑膠質薄膜係將至少4層以上之膜藉由共壓出法以一個步驟進行多層製膜。共壓出法可為藉由多層T塑模成形之片狀物的製膜,亦可為藉由多層吹膜之筒狀的製膜,但製作醫療用容器袋時,為使儲存藥液之薄膜內面不易暴露於外而以筒狀為佳。進而為使其表現高透明性,以自熔融狀態施以急冷固化的水冷式共壓出吹膜法為佳。In the plastic film of the present invention, at least four or more films are formed into a multilayer film in one step by a co-extrusion method. The co-extrusion method may be a film formation of a sheet formed by multilayer T molding, or a film formation by a multi-layer blown film, but when a medical container bag is produced, in order to store the liquid medicine The inner surface of the film is not easily exposed to the outside but is preferably in the form of a cylinder. Further, in order to exhibit high transparency, a water-cooled co-extrusion blown film method in which a quenching and solidification is applied from a molten state is preferred.
針對本發明以實施例更具體說明。The invention will be more specifically described by way of examples.
實施例1~4及比較例1~3中,第1層、第2層、第3層、第4層及密封層使用相異的樹脂,進行塑膠質薄膜製膜。其後,對特定薄膜施以高壓蒸汽滅菌,再針對進行高壓蒸汽滅菌後之薄膜、未進行高壓蒸汽滅菌之薄膜,進行靜置14天後之溶存氧濃度、霧化、外觀及結塊性進行評價。In Examples 1 to 4 and Comparative Examples 1 to 3, the first layer, the second layer, the third layer, the fourth layer, and the sealing layer were formed into a plastic film by using a different resin. Thereafter, the specific film was subjected to autoclaving, and the film after the autoclaving and the film which was not autoclaved were subjected to dissolved oxygen concentration, atomization, appearance and agglomeration after standing for 14 days. Evaluation.
實施例1~4及比較例1~3中第1層、第2層、第3層、第4層及密封層使用下述的樹脂。In the examples 1 to 4 and the comparative examples 1 to 3, the following resins were used for the first layer, the second layer, the third layer, the fourth layer, and the sealing layer.
PA11:尼龍11,Arkema製,RILSAN“BESV 0 A F DA”密度=1.02 g/cm3 ,熔融峰溫度=184℃PA11: Nylon 11, manufactured by Arkema, RILSAN "BESV 0 AF DA" density = 1.02 g/cm 3 , melting peak temperature = 184 ° C
AD:丁烯二酸酐接枝聚丙烯,三菱化學製之ZELAS“MC721AP”密度=0.89 g/cm3 ,MFR=3.5 g/10分鐘,熔融峰溫度=155℃AD: Butane dianhydride grafted polypropylene, ZELAS "MC721AP" density by Mitsubishi Chemical = 0.89 g / cm 3 , MFR = 3.5 g / 10 min, melting peak temperature = 155 ° C
LLD:線性低密度聚乙烯,Primepolymer製,Evolue“SP0511”密度=0.903 g/cm3 ,MFR=1.2 g/10分鐘,熔融峰溫度=110.1℃LLD: Linear low density polyethylene, manufactured by Primepolymer, Evolue "SP0511" density = 0.993 g/cm 3 , MFR = 1.2 g/10 min, melting peak temperature = 110.1 ° C
HD:高密度聚乙烯,日本聚乙烯製,NOVATEC密度=0.955g/cm3 ,MFR=3.5 g/10分鐘,熔融峰溫度=132.4℃HD: high density polyethylene, made of Japanese polyethylene, NOVATEC density = 0.955 g/cm 3 , MFR = 3.5 g/10 min, melting peak temperature = 132.4 ° C
ACT:乙烯-乙烯醇共聚合物為主成份之具有不飽和雙鍵的多烯系聚合物,Kuraray製,PROACT“XEP1190B”密度=1.19 g/cm3 ,MFR=4.0 g/10分鐘,熔融峰溫度=191℃ACT: a polyene polymer having an unsaturated double bond mainly composed of an ethylene-vinyl alcohol copolymer, manufactured by Kuraray, PROACT "XEP1190B" density = 1.19 g/cm 3 , MFR = 4.0 g/10 min, melting peak Temperature = 191 ° C
EVOH:乙烯-乙烯醇共聚合物,Kuraray製,EVAL“L171B”密度=1.20 g/cm3 ,MFR=4.0 g/10分鐘,熔融峰溫度=191℃EVOH: ethylene-vinyl alcohol copolymer, manufactured by Kuraray, EVAL "L171B" density = 1.20 g/cm 3 , MFR = 4.0 g/10 min, melting peak temperature = 191 ° C
將LLD80質量%與HD20質量%之混合物使用於實施例1~2及比較例1~3的密封層中,及比較例3的第1層中。該混合物熔融峰溫度=125℃。A mixture of 80% by mass of LLD and 20% by mass of HD was used in the sealing layers of Examples 1 and 2 and Comparative Examples 1 to 3, and in the first layer of Comparative Example 3. The mixture had a melting peak temperature = 125 °C.
實施例4的密封層係由LLD(80%)+HD(20%)所構成的與第4層鄰接之層120μm,以及與該第4層鄰接之由100%HD所構成的直接熔融密封層10μm此二層構成。The sealing layer of Example 4 is a layer of 120 μm which is composed of LLD (80%) + HD (20%) adjacent to the fourth layer, and a direct molten sealing layer composed of 100% HD adjacent to the fourth layer. This layer consists of 10 μm.
塑膠質薄膜層的製膜係以5種5層或6種6層的水冷式吹膜法製膜機,依下述條件進行。The film formation of the plastic film layer was carried out under the following conditions using five types of five or six types of six-layer water-cooling film forming machine.
第1層:外徑40mm,壓縮比2.7的螺桿壓出機(壓出溫度200℃)The first layer: a screw extruder with an outer diameter of 40 mm and a compression ratio of 2.7 (extrusion temperature of 200 ° C)
第2層:外徑40mm,壓縮比2.7的螺桿壓出機(壓出溫度200℃)The second layer: a screw extruder with an outer diameter of 40 mm and a compression ratio of 2.7 (extrusion temperature of 200 ° C)
第3層:外徑40mm,壓縮比2.7的螺桿壓出機(壓出溫度200℃)The third layer: a screw extruder with an outer diameter of 40 mm and a compression ratio of 2.7 (extrusion temperature of 200 ° C)
第4層:外徑40mm,壓縮比2.7的螺桿壓出機(壓出溫度200℃)The fourth layer: a screw extruder with an outer diameter of 40 mm and a compression ratio of 2.7 (extrusion temperature of 200 ° C)
其中該第4層用的壓出機,於實施例2及比較例2並未進行僅昇溫的壓出。In the extruder for the fourth layer, in Example 2 and Comparative Example 2, only the temperature rise was performed.
密封層:外徑65 mm,壓縮比1.4的螺桿壓出機(壓出溫度210℃)Sealing layer: screw extruder with outer diameter of 65 mm and compression ratio of 1.4 (extrusion temperature 210 ° C)
模具:外徑200 mm,吐出口間隔3 mm,溫度210℃Mold: outer diameter 200 mm, spout interval 3 mm, temperature 210 °C
吹脹比:0.6Blowing ratio: 0.6
製膜速度:13 m/分鐘Film forming speed: 13 m/min
水冷:吐出口外徑120 mm,水溫11.5℃Water cooling: the outer diameter of the spout is 120 mm, and the water temperature is 11.5 °C.
所得薄膜製作成袋後測定溶存氧濃度及霧化,及對外觀及結塊性進行評價。The obtained film was prepared into a bag, and the dissolved oxygen concentration and atomization were measured, and the appearance and agglomeration were evaluated.
取經筒狀製膜之上述薄膜2片,以溫度210℃,壓力0.2MPa下,進行時間0.5秒的熱密封,製作為內寸100×100 mm的三邊熱密封袋。為測定溶存氧濃度,於前述三邊熱密封袋的內面,將溶存氧濃度測定用的檢測晶片以專用接著劑固定。於23℃恆溫室內,將溶存氧濃度7.0~7.5ppm的蒸餾水,以不擾動的狀態移至接有真空幫浦並附蓋的玻璃容器內。再將密封的玻璃容器置於超音波洗淨槽內,進行10分鐘,施加超音波同時以真空幫浦進行脫氣,調製成溶存氧濃度4.8~6.3ppm的蒸餾水。將調製完成的蒸餾水100 ml以不擾動的狀態移至前述的三邊熱密封袋,並快速的把剩下的一邊以熱密封進行密封。密封後的實施例1、3及4、比較例1及3,於121℃下施以25分鐘的高壓蒸汽滅菌。之後,將全部的檢體移至40℃,70%RH的恆溫恆濕槽內,靜置14天。14天後取出靜置的檢體,移至23℃的恆溫室使其降溫至23℃。Two sheets of the above-mentioned film which were formed into a cylindrical film were heat-sealed at a temperature of 210 ° C and a pressure of 0.2 MPa for 0.5 second to prepare a three-side heat-sealed bag having an inner diameter of 100 × 100 mm. In order to measure the dissolved oxygen concentration, the detection wafer for measuring the dissolved oxygen concentration is fixed to the inner surface of the three-side heat-sealed bag by a dedicated adhesive. The distilled water having a dissolved oxygen concentration of 7.0 to 7.5 ppm was transferred to a glass vessel with a vacuum pump and attached thereto in an undisturbed state in a constant temperature chamber at 23 °C. The sealed glass container was placed in an ultrasonic cleaning tank for 10 minutes, and ultrasonic waves were applied while degassing with a vacuum pump to prepare distilled water having a dissolved oxygen concentration of 4.8 to 6.3 ppm. 100 ml of the prepared distilled water was transferred to the aforementioned three-side heat-sealed bag in an undisturbed state, and the remaining side was quickly sealed with a heat seal. The sealed Examples 1, 3 and 4 and Comparative Examples 1 and 3 were autoclaved at 121 ° C for 25 minutes. Thereafter, all the samples were transferred to a constant temperature and humidity chamber at 40 ° C and 70% RH, and allowed to stand for 14 days. After 14 days, the stationary sample was taken out and moved to a constant temperature room at 23 ° C to cool it to 23 ° C.
經過上述處理,藉由非破壞性氧濃度計(三洋貿易製,Fibox-3型),由檢體的檢測晶片測定袋內之溶存氧濃度。Through the above treatment, the dissolved oxygen concentration in the bag was measured from the test wafer of the sample by a non-destructive oxygen concentration meter (Sanyo Trading Co., Ltd., Fibox-3 type).
實施例1、實施例3、實施例4、比較例1及比較例3,取經筒狀製膜之上述薄膜2片,以溫度210℃,壓力0.2MPa下,進行時間0.5秒的熱密封,製作為內寸100×100mm的三邊熱密封袋。於該袋中填充100ml蒸餾水,再將剩下一邊熱密封。其次於121℃,25分鐘條件下,以袋內面一部份緊密黏著的方式進行高壓蒸汽滅菌。之後迅速開封排出蒸餾水,將各實施例及各比較例檢體薄膜於23℃,50RH%溫濕度環境下,進行14天常態調節。將該檢體薄膜依據JIS-K6714操作,測定霧化程度。In the first embodiment, the third embodiment, the fourth embodiment, the comparative example 1 and the comparative example 3, two sheets of the film formed by tubular molding were taken, and heat-sealed at a temperature of 210 ° C and a pressure of 0.2 MPa for 0.5 second. It is a three-side heat-sealed bag with a size of 100×100mm. The bag was filled with 100 ml of distilled water, and the remaining side was heat sealed. Next, autoclaving was carried out at 121 ° C for 25 minutes with a portion of the inner surface of the bag being tightly adhered. Thereafter, the distilled water was quickly opened and the test film of each of the examples and the comparative examples was subjected to a normal adjustment for 14 days under the environment of 23 ° C and 50 RH % temperature and humidity. The sample film was operated in accordance with JIS-K6714, and the degree of atomization was measured.
將實施例2及比較例2中經筒狀製膜之上述薄膜,置於23℃,50RH%溫濕度環境下,進行14天常態調節。將該檢體薄膜依據JIS-K6714操作,測定霧化程度。The film formed into a tubular film in Example 2 and Comparative Example 2 was placed in a 23 ° C, 50 RH % temperature and humidity environment for 14 days of normal adjustment. The sample film was operated in accordance with JIS-K6714, and the degree of atomization was measured.
評價檢體係取經筒狀製膜之上述薄膜2片,以使密封層相接方式重疊,以溫度210℃,壓力0.2MPa下,進行時間0.5秒的熱密封,製作為內寸100×100mm的三邊熱密封袋。在於該袋中填充50ml蒸餾水,以熱密封密封剩下的一邊。以袋內面一部份緊密黏著的方式裝載,再以121℃,25分鐘條件進行高壓蒸汽滅菌。於高壓蒸汽滅菌後觀察袋的外觀,以目視評價有無皺摺。The evaluation system takes two sheets of the above-mentioned film which are formed into a cylindrical film, so that the sealing layers are overlapped, and the heat sealing is performed for 0.5 second at a temperature of 210 ° C and a pressure of 0.2 MPa, and the inner layer is made of 100×100 mm. Heat sealed bag on the side. The bag was filled with 50 ml of distilled water to seal the remaining side with a heat seal. The inside of the bag was loaded in a tightly adhered manner, and autoclaved at 121 ° C for 25 minutes. The appearance of the bag was observed after autoclaving, and the presence or absence of wrinkles was visually evaluated.
結塊評價係於進行高壓蒸汽滅菌後開封時,發現袋的內面可完全分離開,但有一部份仍緊密黏著時,記作「有結塊」,未發現完全緊密黏著之部分時,判定為「無結塊」。The evaluation of the agglomeration was carried out after the autoclave was sterilized. It was found that the inner surface of the bag could be completely separated, but when some parts were still tightly adhered, it was recorded as "caking" and no part was found to be completely adhered. It is "no agglomeration".
所得結果示於表1。The results obtained are shown in Table 1.
表1的檢體薄膜中,實施例1、3、4及比較例1及3,於氧吸收層的兩側之層間接著層具備AD。實施例2及比較例2僅於單側具備AD,且氧吸收層與最外層(第1層)鄰接。In the sample film of Table 1, in Examples 1, 3, and 4 and Comparative Examples 1 and 3, AD was provided in the interlayer between the layers on both sides of the oxygen absorbing layer. In Example 2 and Comparative Example 2, AD was provided only on one side, and the oxygen absorbing layer was adjacent to the outermost layer (first layer).
根據溶存氧濃度,氧吸收層使用ACT之實施例1、3、4未檢出溶存氧,但使用EVOH取代氧吸收層的比較例1~3則顯示高檢出值。由此可得知為使氧吸收層具有功能,不僅須以乙烯-乙烯醇共聚合物為主成分,還需要具有不飽和雙鍵之多烯系聚合體。According to the dissolved oxygen concentration, in the oxygen absorbing layers, the dissolved oxygen was not detected in Examples 1, 3, and 4 using ACT, but Comparative Examples 1 to 3 in which the EVOH was used in place of the oxygen absorbing layer showed a high detection value. From this, it is understood that in order for the oxygen absorbing layer to function, it is necessary to use not only an ethylene-vinyl alcohol copolymer as a main component but also a polyene polymer having an unsaturated double bond.
比較實施例2及比較例2,亦發現即使未施以高壓蒸汽滅菌,使用EVOH取代氧吸收層的比較例2,測得溶存氧濃度。Comparing Example 2 with Comparative Example 2, it was also found that the comparative oxygen concentration of EVOH was used instead of the oxygen absorbing layer, and the dissolved oxygen concentration was measured.
著眼於密封層有關結塊的結果,在密封層由2層構成之實施例4以外,於高壓蒸汽滅菌後將袋開封時,即使用時雖未發現重大的阻礙,但至少有一部份顯示緊密黏著。因此由實施例4的結果可確認,藉由含有僅由高密度聚乙烯構成之直接溶解密封層,密封層不會結塊。然而,當密封層僅由線性低密度聚乙烯構成時,由實施例3可得知會產生皺摺,進而霧化情況較其他實施例更糟。Focusing on the result of agglomeration of the sealing layer, in addition to Example 4 in which the sealing layer was composed of two layers, when the bag was opened after autoclaving, no significant hindrance was observed during use, but at least a part was shown to be tight. Adhesive. Therefore, from the results of Example 4, it was confirmed that the sealing layer did not agglomerate by containing a direct-dissolving sealing layer composed only of high-density polyethylene. However, when the sealing layer was composed only of linear low-density polyethylene, it was found from Example 3 that wrinkles were generated, and the atomization was worse than the other examples.
比較例3的第1層係使用與密封層相同樹脂的薄膜。結塊、皺摺的評價結果,與實施例1及比較例1的結果相同,但霧化狀況較差,進而溶存氧濃度的結果更差。In the first layer of Comparative Example 3, a film of the same resin as the sealing layer was used. The evaluation results of agglomeration and wrinkles were the same as those of Example 1 and Comparative Example 1, but the atomization condition was poor, and the result of the dissolved oxygen concentration was further inferior.
著眼於第1層的熔融峰溫度與密封層的熔融峰溫度之差時,例如在實施例4,第1層(184℃:PA11)-密封層(132℃:HD100%)其差異為52℃。然而在比較例3中,由於第1層係使用與密封層相同的樹脂,熔融峰溫度之差為0℃。When focusing on the difference between the melting peak temperature of the first layer and the melting peak temperature of the sealing layer, for example, in Example 4, the first layer (184 ° C: PA11)-sealing layer (132 ° C: HD 100%) has a difference of 52 ° C. . However, in Comparative Example 3, since the first layer was made of the same resin as the sealing layer, the difference in melting peak temperatures was 0 °C.
由以上結果,可得知含有碳數為11以上之尼龍11的最外層、含有作為氧吸收層之具有不飽和雙鍵的多烯系聚合物之ACT、於ACT兩側作為層間接著層之AD、亦即具備第1層間接著層及第2層間接著層;進而含有密封層為保持一般的透明性及柔軟性之密封層、直接熔融密封層、及含有二者之層之實施例4,雖然有稍許霧化,但具優異氧吸收功能,且密封層未發現皺摺及結塊,為合適的薄膜。From the above results, it was found that the outermost layer of the nylon 11 having a carbon number of 11 or more, the ACT containing the polyene polymer having an unsaturated double bond as the oxygen absorbing layer, and the AD as the interlayer of the interlayer on the ACT side. That is, the first interlayer adhesive layer and the second interlayer adhesive layer are provided, and the sealing layer is a sealing layer for maintaining general transparency and flexibility, a direct melt sealing layer, and a layer containing both layers, although It has a slight atomization, but it has excellent oxygen absorption function, and the sealing layer is not wrinkled and agglomerated, which is a suitable film.
本發明之塑膠質薄膜係無須外包材,且不使用有機溶劑系接著劑,可有效吸收藥液中的溶存氧,由於不會產生高壓蒸汽滅菌的白化問題,可廣泛利用於輸液及經腸營養劑等醫療用容器等。The plastic film of the invention does not require an outer covering material, and does not use an organic solvent-based adhesive, can effectively absorb dissolved oxygen in the chemical liquid, and can be widely used in infusion and enteral nutrition because it does not cause whitening problem of high-pressure steam sterilization. Medical containers such as agents.
1...最外層1. . . Outermost layer
2...氧吸收層2. . . Oxygen absorbing layer
3、31、32...層間接著層3, 31, 32. . . Interlayer
4...密封層4. . . Sealing layer
10...塑膠質薄膜10. . . Plastic film
11...注入口11. . . Note entry
12...第1端熱密封部12. . . First end heat seal
13...輸液收納部13. . . Infusion storage unit
14...第2端熱密封部14. . . Second end heat seal
15...懸吊孔15. . . Suspension hole
16...未密封部16. . . Unsealed part
41...保持透明性及柔軟性的密封層41. . . Sealing layer that maintains transparency and softness
42...直接熔融密封層42. . . Direct melt seal
[圖1]本發明之塑膠質薄膜其一例的部份剖面圖。Fig. 1 is a partial cross-sectional view showing an example of a plastic film of the present invention.
[圖2]本發明之塑膠質薄膜其變形例的部份剖面圖。Fig. 2 is a partial cross-sectional view showing a modification of the plastic film of the present invention.
[圖3]本發明之塑膠質薄膜其變形例的部份剖面圖。Fig. 3 is a partial cross-sectional view showing a modification of the plastic film of the present invention.
[圖4]本發明之塑膠質薄膜其變形例的部份剖面圖。Fig. 4 is a partial cross-sectional view showing a modification of the plastic film of the present invention.
[圖5]使用本發明之塑膠質薄膜製做之輸液袋其一例的平面圖。Fig. 5 is a plan view showing an example of an infusion bag made of the plastic film of the present invention.
1...最外層1. . . Outermost layer
2...氧吸收層2. . . Oxygen absorbing layer
3...層間接著層3. . . Interlayer
4...密封層4. . . Sealing layer
Claims (7)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009251627 | 2009-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201130955A TW201130955A (en) | 2011-09-16 |
TWI438264B true TWI438264B (en) | 2014-05-21 |
Family
ID=43922197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW99137466A TWI438264B (en) | 2009-11-02 | 2010-11-01 | Plastic film and infusion bag having oxigen absorption capability |
Country Status (10)
Country | Link |
---|---|
US (1) | US8708992B2 (en) |
EP (1) | EP2497453B1 (en) |
JP (1) | JP5492905B2 (en) |
KR (1) | KR101423079B1 (en) |
CN (1) | CN102596144B (en) |
AU (1) | AU2010312385B2 (en) |
BR (1) | BR112012010283A2 (en) |
RU (1) | RU2496466C1 (en) |
TW (1) | TWI438264B (en) |
WO (1) | WO2011052776A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9861733B2 (en) | 2012-03-23 | 2018-01-09 | Nxstage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
AU2012230767A1 (en) | 2011-03-23 | 2013-10-31 | Nxstage Medical, Inc. | Peritoneal dialysis systems, devices, and methods |
JP5954325B2 (en) * | 2011-06-27 | 2016-07-20 | 三菱瓦斯化学株式会社 | Multilayer sheet |
JP5954323B2 (en) * | 2011-06-27 | 2016-07-20 | 三菱瓦斯化学株式会社 | Multilayer film and film packaging container |
RU2013158170A (en) * | 2011-06-27 | 2015-08-10 | Мицубиси Гэс Кемикал Компани, Инк. | MULTILAYER PRODUCT OBTAINED BY PRESSURE INJECTION |
JP2013091259A (en) * | 2011-10-26 | 2013-05-16 | Hosokawa Yoko Co Ltd | Plastic film |
EP2790918A1 (en) | 2011-12-15 | 2014-10-22 | Windmöller & Hölscher KG | Film product for packaging products in sealed film packages |
EP2855556A4 (en) * | 2012-05-25 | 2016-02-10 | Polyone Corp | Oxygen scavenging copolymers made from cyclic aliphatic monomers |
KR101289691B1 (en) * | 2012-11-22 | 2013-08-01 | 주식회사 에스에프씨 | Packing pouch for photoresist |
CH707854A2 (en) | 2013-03-20 | 2014-09-30 | Alpla Werke | Extrusion blow tube. |
CN105307854B (en) * | 2013-06-07 | 2017-10-27 | 株式会社细川洋行 | Film for infusion bag and the infusion bag using film for infusion bag |
CN106102651B (en) * | 2014-03-20 | 2019-01-22 | 厄耳他拉登脱产品股份有限公司 | Packaging system including sacrificial compositions |
CN106456441A (en) * | 2014-04-03 | 2017-02-22 | 丘比株式会社 | Injection fluid bag and injection preparation |
JP6403999B2 (en) * | 2014-06-05 | 2018-10-10 | 株式会社細川洋行 | Retort packaging laminate and container |
CN106794683A (en) * | 2014-10-03 | 2017-05-31 | 纳幕尔杜邦公司 | Multilayer food product casing or food-film |
WO2017021496A1 (en) | 2015-08-04 | 2017-02-09 | Dsm Ip Assets B.V. | Co-extruded film |
CN105504622B (en) * | 2015-12-26 | 2017-08-25 | 宿州市逢源生物科技有限公司 | A kind of preparation method of acrylic resin modified infusion bag |
BR112019012629B1 (en) * | 2016-12-29 | 2022-09-27 | Tetra Laval Holdings & Finance S.A | PACKAGING FOR SPILLABLE FOOD PRODUCTS, AND METHOD TO PROVIDE AN OPENING PORTION. |
WO2018237375A1 (en) | 2017-06-24 | 2018-12-27 | Nxstage Medical, Inc. | Peritoneal dialysis fluid preparation and/or treatment devices methods and systems |
EP3804686B1 (en) * | 2017-10-10 | 2023-08-30 | Sun Pharmaceutical Industries Ltd | Intravenous infusion dosage form for pemetrexed |
US11872337B2 (en) | 2018-02-28 | 2024-01-16 | Nxstage Medical, Inc. | Fluid preparation and treatment devices methods and systems |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254169A (en) * | 1978-12-28 | 1981-03-03 | American Can Company | Multi-layer barrier film |
US4397916A (en) | 1980-02-29 | 1983-08-09 | Mitsui Petrochemical Industries, Ltd. | Laminated multilayer structure |
JPS56120344A (en) * | 1980-02-29 | 1981-09-21 | Mitsui Petrochemical Ind | Multilayer laminated structure |
JPH09109274A (en) * | 1995-10-19 | 1997-04-28 | Dainippon Printing Co Ltd | Manufacture for inflation film |
JP3716879B2 (en) * | 1996-05-24 | 2005-11-16 | 藤森工業株式会社 | Plastic film for medical liquid containers |
US6083587A (en) | 1997-09-22 | 2000-07-04 | Baxter International Inc. | Multilayered polymer structure for medical products |
US6179823B1 (en) * | 1998-01-20 | 2001-01-30 | Bracco Research Usa | Multiple use universal connector flexible medical container assembly |
DE69821221T2 (en) * | 1998-06-20 | 2004-11-04 | Sweco S.A. | Multi-layer plastic hose with barrier layer structures |
US6479160B1 (en) * | 2001-03-09 | 2002-11-12 | Honeywell International Inc. | Ultra high oxygen barrier films and articles made therefrom |
US20030077466A1 (en) * | 2001-10-19 | 2003-04-24 | Smith Sidney T. | Multilayered polymer structure |
JP4026417B2 (en) * | 2002-06-04 | 2007-12-26 | 東洋製罐株式会社 | Resin composition and multilayer packaging material using the same |
JP4335049B2 (en) * | 2004-03-29 | 2009-09-30 | 中本パックス株式会社 | Laminated film for infusion bags |
KR101150566B1 (en) | 2004-10-18 | 2012-06-08 | 가부시키가이샤 오츠까 세이야꾸 고죠 | Gas barrier film for medical use and medical bags made by using the same |
CN101305026B (en) * | 2005-03-17 | 2011-08-10 | 陶氏环球技术有限责任公司 | Compositions of ethylene/alpha-olefin multi-block interpolymer for blown films with high hot tack |
JP2007283565A (en) | 2006-04-14 | 2007-11-01 | Mitsubishi Plastics Ind Ltd | Gas barrier film, packaging material using it and package |
JP4853169B2 (en) | 2006-08-10 | 2012-01-11 | 凸版印刷株式会社 | Package |
US20090029079A1 (en) * | 2007-07-23 | 2009-01-29 | Viskase Companies, Inc. | Nylon Food Casing |
US8815360B2 (en) * | 2007-08-28 | 2014-08-26 | Cryovac, Inc. | Multilayer film having passive and active oxygen barrier layers |
JP5286779B2 (en) * | 2007-12-27 | 2013-09-11 | 大日本印刷株式会社 | Packaging bags for medical plastic containers |
AU2010309023B2 (en) * | 2009-10-20 | 2014-03-27 | Hosokawa Yoko Co., Ltd. | Plastic film and infusion bag |
-
2010
- 2010-11-01 TW TW99137466A patent/TWI438264B/en not_active IP Right Cessation
- 2010-11-02 AU AU2010312385A patent/AU2010312385B2/en not_active Ceased
- 2010-11-02 EP EP10826906.9A patent/EP2497453B1/en not_active Not-in-force
- 2010-11-02 JP JP2011538522A patent/JP5492905B2/en active Active
- 2010-11-02 CN CN201080048762.9A patent/CN102596144B/en not_active Expired - Fee Related
- 2010-11-02 US US13/504,323 patent/US8708992B2/en active Active
- 2010-11-02 RU RU2012120476/15A patent/RU2496466C1/en active
- 2010-11-02 BR BR112012010283A patent/BR112012010283A2/en not_active IP Right Cessation
- 2010-11-02 KR KR1020127010736A patent/KR101423079B1/en active IP Right Grant
- 2010-11-02 WO PCT/JP2010/069477 patent/WO2011052776A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2497453A1 (en) | 2012-09-12 |
KR20120070592A (en) | 2012-06-29 |
CN102596144A (en) | 2012-07-18 |
JPWO2011052776A1 (en) | 2013-03-21 |
AU2010312385B2 (en) | 2013-12-12 |
JP5492905B2 (en) | 2014-05-14 |
US8708992B2 (en) | 2014-04-29 |
AU2010312385A1 (en) | 2012-05-31 |
WO2011052776A1 (en) | 2011-05-05 |
RU2496466C1 (en) | 2013-10-27 |
EP2497453A4 (en) | 2013-11-13 |
KR101423079B1 (en) | 2014-07-24 |
EP2497453B1 (en) | 2017-08-30 |
BR112012010283A2 (en) | 2016-03-29 |
TW201130955A (en) | 2011-09-16 |
US20120215196A1 (en) | 2012-08-23 |
CN102596144B (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI438264B (en) | Plastic film and infusion bag having oxigen absorption capability | |
US10633158B2 (en) | Laminate for retort packaging and container | |
JP7408561B2 (en) | Multilayer structure and packaging material using the same | |
TWI444291B (en) | Plastic film and infusion bag | |
TWI577370B (en) | Injection bag and injection preparation | |
JP5686531B2 (en) | Plastic film and molded container using the same | |
JP7096246B2 (en) | Co-injection molded multilayer structure and its manufacturing method | |
CN110062698B (en) | Co-injection molding of multilayer structures | |
KR101749853B1 (en) | Easily releasable multilayer film and package formed of same | |
JP2007099767A (en) | Heparin injection solution preparation | |
JP2017164297A (en) | Blood bag for fresh frozen plasma preparation | |
JPH02235632A (en) | Laminated long article | |
JP4062379B2 (en) | Deoxygenating multilayer body and packaging container | |
JPS601225B2 (en) | Transparent laminated film container with excellent dimensional stability and its manufacturing method | |
JPH02209241A (en) | Laminated long article |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |